The Plasma Membrane: A Target and Hurdle for the Development of Anti-A&bgr; Drugs?

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|1|6|567-574

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.6, 2002-12, pp. : 567-574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs

By  

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1688-1698

Bentham Science Publishers

Access to resources Recommend Favorite

&bgr;3-Adrenergic Receptors: Really Relevant Targets for Anti-Obesity Drugs?

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 3, 2003-09 ,pp. : 257-273

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Modulation of A&bgr;42 Production in Alzheimer's Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4337-4355

Bentham Science Publishers

Access to resources Recommend Favorite

Development of anti-obesity agents: drugs that target neuropeptide and neurotransmitter systems

By Fong Tung M  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 321-325

Informa Healthcare

Access to resources Recommend Favorite

Transforming Growth Factor-&bgr;: A Molecular Target for the Future Therapy of Glioblastoma

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 341-349

Bentham Science Publishers

Access to resources Recommend Favorite